[
  {
    "ts": null,
    "headline": "EMA's CHMP Re-Examines Rejection Of Kisunla For Early Alzheimer'S Treatment",
    "summary": "EMA's CHMP: * POSITIVE OPINION WAS ADOPTED FOR OGSIVEO, FOR THETREATMENT OFADULTS WITH PROGRESSING DESMOID TUMOURS * NINTEDANIB VIATRIS GOT POSITIVE OPINION FOR...",
    "url": "https://finnhub.io/api/news?id=f8acd1d03d74ff71924fec8eccdce309f1d1e96250e4cbca38ec4c77b9e194a9",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750400301,
      "headline": "EMA's CHMP Re-Examines Rejection Of Kisunla For Early Alzheimer'S Treatment",
      "id": 135423691,
      "image": "",
      "related": "VTRS",
      "source": "Finnhub",
      "summary": "EMA's CHMP: * POSITIVE OPINION WAS ADOPTED FOR OGSIVEO, FOR THETREATMENT OFADULTS WITH PROGRESSING DESMOID TUMOURS * NINTEDANIB VIATRIS GOT POSITIVE OPINION FOR...",
      "url": "https://finnhub.io/api/news?id=f8acd1d03d74ff71924fec8eccdce309f1d1e96250e4cbca38ec4c77b9e194a9"
    }
  }
]